Loading…

Design, synthesis and molecular docking studies of some novel spiro[indoline-3, 4′-piperidine]-2-ones as potential c-Met inhibitors

Deregulation of receptor tyrosine kinase c-Met has been reported in human cancers and is considered as an attractive target for small molecule drug discovery. In this study, a series of spiro[indoline-3, 4′-piperidine]-2-ones were designed, synthesized and evaluated as novel c-Met inhibitors. The re...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry 2012-04, Vol.50, p.370-375
Main Authors: Ye, Lianbao, Tian, Yuanxin, Li, Zhonghuang, Jin, Hong, Zhu, Zhengguang, Wan, Shanhe, Zhang, Junyan, Yu, Pengjiu, Zhang, Jiajie, Wu, Shuguang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Deregulation of receptor tyrosine kinase c-Met has been reported in human cancers and is considered as an attractive target for small molecule drug discovery. In this study, a series of spiro[indoline-3, 4′-piperidine]-2-ones were designed, synthesized and evaluated as novel c-Met inhibitors. The results showed that the majority of the compounds exhibited significant inhibitory effect on c-Met with IC50 values of 0.0147–17 μM in TR-FRET-based assay and IC50 values of 1.56–1400 μM in cell-based assay. Furthermore, our docking experiments verified the results and explained the molecular mechanism of eminent activities to c-Met. [Display omitted] ► We design and synthesize some novel spiro[indoline-3, 4′-piperidine]-2-ones. ► We investigate their inhibitory effect on c-Met with biological assay. ► Biological assay IC50 values are 0.0147–17 μM and cell IC50 values are 1.56–1400 μM. ► We explain molecular mechanism of eminent activities to c-Met by molecular docking.
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2012.02.016